ArticleBMC infectious diseases2025
Molecular surveillance of influenza A and B in namibia: seasonal patterns and clinical correlates (2021-2023).
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Temporal trends and burden of influenza B virus lineages in Dibrugarh, Assam (2014-2025): predominance of Victoria with early circulation of Yamagata.Archives of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluenza viruses cause widespread respiratory illness. Due to limited surveillance, influenza dynamics in Namibia remain poorly understood. This study aimed to conduct molecular surveillance of influenza A and B viruses from 2021 − 2023, characterize circulating strains, and explore symptom correlations to inform public health responses and improve case management.
methodsFrom October 2021 to December 2023, nasopharyngeal or oropharyngeal swabs were collected from patients with influenza-like illness (ILI) in a clinic-based setting. Viral detection, subtyping, and genotyping were conducted using real-time reverse-transcription polymerase chain reaction (RT-PCR). Seasonal trends of influenza and SARS-CoV-2, as well as symptom co-occurrence patterns were examined using statistical and visualization tools in R, Epi Info, and SPSS.
resultsA total of 1186 nasopharyngeal and oropharyngeal samples form ILI patients were collected. Influenza was detected in 25.7% (280/1088) of samples, with influenza A accounting for 20.2% (235/1162) and influenza B for 4.3% (45/1049). Among influenza A cases, A(H1N1)pdm09 was detected in 26.4% (62/235) and A(H3N2) in 67% (157/235). Influenza B (Victoria) accounted for nearly all influenza B cases (96%), while no influenza B(Yamagata) cases were detected. SARS-CoV-2 was detected in 19.2% (227/1182) of samples. Significant associations were observed between influenza infection and cough (OR 2.2, 95% CI 1.2 − 3.9, p = 0.0076) and myalgia (OR 2.3, 95% CI 1.5 − 3.6, p = 0.00044). The strongest correlation was between loss of smell and loss of taste (r = 0.71, p < 0.001).
conclusionsInfluenza activity followed distinct seasonal patterns, with influenza A more common than B. Cough and myalgia were stronger predictors of infection, while sore throat and loss of smell were less so. These findings highlight the importance of ongoing influenza surveillance and preparedness to manage seasonal outbreaks, while symptom correlations can enhance case management and monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.